PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses.

@article{Benn2010PCSK9RL,
  title={PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses.},
  author={Marianne Benn and B\orge G. Nordestgaard and P. Grande and Peter Schnohr and Anne Tybjaerg-Hansen},
  journal={Journal of the American College of Cardiology},
  year={2010},
  volume={55 25},
  pages={2833-42}
}
OBJECTIVES The aim of this study was to examine the effect of PCSK9 R46L on low-density lipoprotein cholesterol (LDL-C), risk of ischemic heart disease (IHD), and mortality. BACKGROUND The 46L allele has been associated with reductions in LDL-C and risk of IHD, but results vary between studies. METHODS We determined the association of R46L genotype with… CONTINUE READING